Subscribe To

Price Alert Latest News Economic Calendar News

BNR / Burning Rock Schedules Fourth Quarter and Full Year 2021 Earnings Release on March 22, 2022

GUANGZHOU, China, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that it plans to release its unaudited financial results for the fourth quarter and full year 2021 before the U.S. market opens on March 22, 2022. Following the release, company management will host a conference call at 8:00 a.m. ET (8:00 p.m. Hong Kong time) on the same day to discuss its financial results for the fourth quarter and full year 2021. Read More

Demo Live Account See Partner Details

Content Topics

Burning

Rock

Schedules

Fourth

Quarter

Full

Year

2021

Earnings

Release

Stock

BNR

Posted: Feb 21 2022, 23:30

Author Name: GlobeNewsWire

BNR News

By Seeking Alpha
August 31, 2023

Burning Rock Biotech Limited (BNR) Q2 2023 Earnings Call Transcript

Burning Rock Biotech Limited (NASDAQ:BNR ) Q2 2023 Earnings Conference Call August 31, 2023 8:00 AM ET Company Participants Yusheng Han - Founder, Cha

By GlobeNewsWire
August 4, 2023

Burning Rock Provides Second Quarter 2023 Business Updates and Schedules Earnings Release on August 31, 2023

GUANGZHOU, China, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”),

By Seeking Alpha
May 30, 2023

Burning Rock Biotech Limited (BNR) Q1 2023 Earnings Call Transcript

Burning Rock Biotech Limited (NASDAQ:BNR ) Q1 2023 Earnings Conference Call May 30, 2023 8:00 AM ET Company Participants Yusheng Han - Founder, Chairm

By GlobeNewsWire
April 27, 2023

Burning Rock Provides First Quarter 2023 Business Updates and Schedules Earnings Release on May 30, 2023

GUANGZHOU, China, April 27, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”),

By Zacks Investment Research
November 21, 2022

Burning Rock Biotech Limited Sponsored ADR (BNR) Upgraded to Buy: What Does It Mean for the Stock?

Burning Rock Biotech Limited Sponsored ADR (BNR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings

By Zacks Investment Research
August 31, 2022

Burning Rock Biotech Limited Sponsored ADR (BNR) Reports Q2 Loss, Tops Revenue Estimates

Burning Rock Biotech Limited Sponsored ADR (BNR) delivered earnings and revenue surprises of -2.78% and 0.69%, respectively, for the quarter ended Jun

By GlobeNewsWire
August 4, 2022

Burning Rock Provides Second Quarter 2022 Business Updates and Schedules Earnings Release on August 31, 2022

GUANGZHOU, China, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company foc

By GlobeNewsWire
May 16, 2022

Burning Rock Schedules First Quarter of 2022 Earnings Release on May 31, 2022

GUANGZHOU, China, May 16, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focu

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.